Jaime Bartushak
Chief Financial Officer · CITIUS ONCOLOGY, INC.
Individual
- 2024
- Dec 22, 2025
- 5
Other insiders active in the same sector
No other insider has filed at Jaime Bartushak's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- LILLY ENDOWMENT INC - $2.23B in LLY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jaime Bartushak?
Jaime Bartushak is a corporate insider, tracked as Chief Financial Officer of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jaime Bartushak last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
